Bupivacaine Epiphora Trial
| Status: | Suspended |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/9/2019 |
| Start Date: | April 2015 |
| End Date: | August 2021 |
Improving Epiphora & Ptosis With Bupivacaine
The objective of this study is to investigate quantitative improvement in excessive tearing
after administration of Bupivacaine, a local anesthetic, into the affected eyelids.
after administration of Bupivacaine, a local anesthetic, into the affected eyelids.
Inclusion Criteria:
Patients age 18 and above, patients with unilateral or bilateral excessive tearing.
Exclusion Criteria:
Pregnant females, vulnerable populations, patients with severe hepatic disease, or patients
using monoamine oxidase inhibitors or tricyclic antidepressants, which are contraindicated
with bupivacaine and norepinephrine combinations.
We found this trial at
1
site
Icahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai is...
Click here to add this to my saved trials
